bullish
SK Biopharmaceuticals - KOSPI200 Inclusion Confirmed, Large Impact Expected
373 Views10 Aug 2020 05:33
Late Friday evening, the KRX confirmed something that was widely expected. SK Biopharmaceuticals (326030 KS) meets the Fast Entry criteria for...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
- MSCI Korea Nov IR: Constituent Replacements21 Oct 2020
- MSCI Korea Nov20 Index Rebalance Preview: Quite a Few Changes With Big Impact18 Oct 2020
- KOSPI200 Index Rebalance Preview: Adds Outperform Deletes; Short Sell Ban The Wildcard27 Aug 2020
- SK Biopharmaceuticals - KOSPI200 Inclusion Confirmed, Large Impact Expected10 Aug 2020
- SK Biopharmaceuticals - Index Fast Entry Possibilities: KOSPI200, FTSE, MSCI03 Jul 2020
- SK Biopharmaceuticals - Fast Index Entry Possibilities03 Jun 2020
x